Political Quotes

John Conyers: We have received the quotations from President Clinton and former Presidents, but let us look at what the gentleman from…

On the recordApril 18, 1996
We have received the quotations from President Clinton and former Presidents, but let us look at what the gentleman from Illinois [Mr. Hyde] is talking about. He is proud of the fact that we implement the convention on marketing plastic explosives that was noncontroversial. Restrictions on biological and chemical weapons, hooray, that was uncontroversial. We got in the bill mandatory victim restitution. Do you remember anybody ever quarreling with that? Not hardly. Mr. Speaker, now we come to all of the Barr provisions that were killed out of this bill by 246 votes, a majority. Remember that? That was not such a great day on the floor, because the gentleman from Georgia [Mr. Barr] thought we should not strengthen the criminal alien deportation procedure, so he kicked it out and it won. The gentleman from Georgia [Mr. Barr] thought that we should not expedite the deportation of terrorists, and it won and we kicked it out. The gentleman from Georgia [Mr. Barr] thought that there should not be a ban on fundraising by terrorist groups, and he won and we kicked it out. Now in the conference we got pieces of it back in. I am very happy that the chairman of the Committee on the Judiciary wishes that we had wiretap authority for terrorists, not for stealing cars, not for hijacking, not for simple felony crimes, but terrorism, this one thing that we are dealing with so completely here this afternoon.
Said by
John Conyers
Democratic · Michigan

Editor's note · Context

Discussing provisions related to terrorism and criminal deportation in a bill.

Share

More from John Conyers

Oct 31, 2017

I am a cosponsor of her legislation with great pride.

congress.gov
Jul 26, 2017

I support the idea of making prescription drugs affordable and accessible for all Americans, for everybody.

congress.gov
Jul 26, 2017

We should of course remain vigilant about pay-for-delay schemes, whereby branded drug manufacturers pay generic manufacturers to delay the entry of a version of branded drugs as the patent on the branded drug expires.

congress.gov

Other voices in this conversation